Pilot randomized, non-inferiority, cross-over trial of once-weekly vs. three times-weekly recombinant factor VIII prophylaxis in adults with severe haemophilia A.

Ragni, M V; Yabes, J G; Fogarty, P F; Josephson, N C; Kessler, C M; Neff, A T; Raffini, L; Brummel-Ziedins, K; Moore, C G

Ragni, M V; Yabes, J G; Fogarty, P F; Josephson, N C; Kessler, C M; Neff, A T; Raffini, L; Brummel-Ziedins, K; Moore, C G.

Afiliación

Ragni MV; Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Yabes JG; Hemophilia Center of Western Pennsylvania, Pittsburgh, PA, USA.
Fogarty PF; Center for Research on Health Care Data Center, University of Pittsburgh, Pittsburgh, PA, USA.
Josephson NC; University of Pennsylvania, Philadelphia, PA, USA.
Kessler CM; Puget Sound Blood Center, Seattle, WA, USA.
Neff AT; Georgetown University Medical Center, Washington, DC, USA.
Raffini L; Vanderbilt University Medical Center, Nashville, TN, USA.
Brummel-Ziedins K; Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Moore CG; Department of Biochemistry, University of Vermont, Colchester, VT, USA.

Haemophilia ; 23(1): e43-e46, 2017 Jan.

Article en En | MEDLINE | ID: mdl-27943502

Asunto(s)

Factor VIII/uso terapéutico; Hemofilia A/tratamiento farmacológico; Estudios Cruzados; Humanos; Masculino; Proyectos Piloto

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factor VIII / Hemofilia A Tipo de estudio: Clinical_trials Límite: Humans / Male Idioma: En Revista: Haemophilia Asunto de la revista: HEMATOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google